First Page | Document Content | |
---|---|---|
![]() Date: 2015-12-21 11:29:00Amphetamine Methylphenidate Attention deficit hyperactivity disorder Stimulants Phenethylamines Attention deficit hyperactivity disorder management Off-label use Atomoxetine Adult attention deficit hyperactivity disorder Placebo Pemoline Lisdexamfetamine | Add to Reading List |
![]() | Listing By ClassificationDocID: 1qDsa - View Document |
![]() | prilTreatments for Attention Deficit Hyperactivity Disorder in Adults FINAL PHARMACOEPIDEMIOLOGY REPORTDocID: 1pBj0 - View Document |
![]() | NCAA Banned Drugs and Medical Exceptions Policy Guidelines Regarding Medical Reporting for Student-Athletes with Attention Deficit Hyperactivity Disorder (ADHD) Taking Prescribed Stimulants The NCAA bans classes of drugDocID: 1pvtZ - View Document |
![]() | NCAA Guidelines to Document ADHD Treatment with Banned Stimulant Medications Addendum to the January 2009 Guidelines Q & A MarchWhy is the NCAA instituting a stricter application of the medical exception policyDocID: 1oviK - View Document |
![]() | prilFINAL CONSOLIDATED REPORT DecemberDrugs Used in the Management ofDocID: 1ou1z - View Document |